Manager, Commercial ExcellencePTC Therapeutics, Inc.Conroe, Texas, United States
Disclosure information not submitted.
Paper 80 - A PHASE 2/3 STUDY EVALUATING THE EFFICACY AND SAFETY OF UNESBULIN IN ADVANCED LEIOMYOSARCOMA (SUNRISELMS)
Saturday, November 16, 20249:00 AM – 10:00 AM PST